Gene therapy for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss associated with biallelic variants in the otoferlin (OTOF) gene.
Gene therapy for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss associated with biallelic variants in the otoferlin (OTOF) gene.